Interpharm Holdings (IPAH) Financial Statements
Interpharm Holdings Financial Overview
Interpharm Holdings's market cap is currently $67. The company's EPS TTM is ―; its P/E ratio is 0.00; Interpharm Holdings has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 07 | Jun 06 | Jun 05 | Jun 04 | Jun 03 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 21.67M | $ 17.43M | $ 9.07M | $ 9.79M | $ 2.74M |
| Operating Income | $ -10.74M | $ -4.77M | $ -95.00K | $ 5.06M | $ 1.24M |
| EBITDA | $ -8.18M | $ -3.23M | $ 1.15M | $ 5.95M | $ 1.56M |
| Net Income | $ -14.06M | $ -3.79M | $ -149.00K | $ 3.12M | $ 723.64K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 74.37M | $ 62.87M | $ 46.39M | $ 35.17M | $ 20.34M |
| Total Debt | $ 26.55M | $ 15.64M | $ 17.03M | $ 7.83M | $ 2.53M |
| Net Debt | $ 26.47M | $ 14.20M | $ 16.49M | $ 4.90M | $ 141.89K |
| Total Liabilities | $ 62.95M | $ 40.04M | $ 23.28M | $ 12.38M | $ 7.87M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -22.11M | $ -6.03M | $ -10.46M | $ -2.30M | $ -830.97K |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD